​

Sensei Biotherapeutics (SNSE) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

SNSE Stock Forecast

Sensei Biotherapeutics (SNSE) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $5.50, with a high of $6.00 and a low of $5.00. This represents a -82.70% decline from the last price of $31.79.

- $7 $14 $21 $28 $35 High: $6 Avg: $5.5 Low: $5 Last Closed Price: $31.79

SNSE Stock Rating

Sensei Biotherapeutics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (66.67%), 2 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 2 4 0 Strong Sell Sell Hold Buy Strong Buy

SNSE Price Target Upside V Benchmarks

TypeNameUpside
StockSensei Biotherapeutics-82.70%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$31.79$31.79$31.79
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-11--2
Jan, 26--1--1
Dec, 25--1--1
Nov, 25111--3
Oct, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 13, 2024Sudan LoganathanStephens$5.00$1.57218.47%-84.27%
Dec 13, 2022Citigroup$6.00$1.74244.83%-81.13%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 30, 2025H.C. WainwrightBuyNeutraldowngrade
Aug 05, 2025H.C. WainwrightBuyBuyhold
May 13, 2024StephensOverweightinitialise
Dec 13, 2022CitigroupBuyinitialise
Oct 03, 2022OppenheimerOutperformupgrade

Financial Forecast

EPS Forecast

$-20 $-16 $-12 $-8 $-4 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.22$-1.20$-16.72---
Avg Forecast$-1.23$-1.17$-0.63$-0.66$-0.78$-0.81
High Forecast$-1.22$-1.14$-0.32$-0.61$-0.78$-0.81
Low Forecast$-1.23$-1.19$-1.03$-0.70$-0.78$-0.81
Surprise %-0.81%2.56%2553.97%---

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-35M $-29M $-23M $-17M $-11M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-34.10M$-30.16M$-21.09M---
Avg Forecast$-34.24M$-32.47M$-26.75M$-18.31M$-21.80M$-22.64M
High Forecast$-34.10M$-31.78M$-8.95M$-17.05M$-21.80M$-22.64M
Low Forecast$-34.38M$-33.17M$-28.90M$-19.57M$-21.80M$-22.64M
Surprise %-0.41%-7.13%-21.19%---

SNSE Forecast FAQ

Is Sensei Biotherapeutics stock a buy?

Sensei Biotherapeutics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Sensei Biotherapeutics is a favorable investment for most analysts.

What is Sensei Biotherapeutics's price target?

Sensei Biotherapeutics's price target, set by 6 Wall Street analysts, averages $5.5 over the next 12 months. The price target range spans from $5 at the low end to $6 at the high end, suggesting a potential -82.70% change from the previous closing price of $31.79.

How does Sensei Biotherapeutics stock forecast compare to its benchmarks?

Sensei Biotherapeutics's stock forecast shows a -82.70% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Sensei Biotherapeutics over the past three months?

  • April 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Sensei Biotherapeutics’s EPS forecast?

Sensei Biotherapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.66, marking a -96.05% decrease from the reported $-16.72 in 2025. Estimates for the following years are $-0.78 in 2027, and $-0.81 in 2028.

What is Sensei Biotherapeutics’s revenue forecast?

Sensei Biotherapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, and $0 for 2028.

What is Sensei Biotherapeutics’s net income forecast?

Sensei Biotherapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-18.309M, representing a -13.17% decrease from the reported $-21.085M in 2025. Projections indicate $-21.803M in 2027, and $-22.642M in 2028.